| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 04.11. | FortifAI (ASX:FTI) NVIDIA Hire Joins as the Commercial Test Begins | ||
| 04.11. | Telix Pharmaceuticals (ASX:TLX) Imaging Built the Business. Can Therapies Drive the Next Leg of Growth | ||
| 04.11. | Block (NYSE:XYZ) lifts Q3 gross profit 22% and Cash App hits 60 million | ||
| 03.11. | AMD (NASDAQ:AMD) Q3 Earnings: Can AI Chip Growth Reverse the Stock's 23% Selloff? | ||
| 03.11. | Lattice Semiconductor (NASDAQ:LSCC) Stock Surges 13% After Revenue Jumps 118% on AI Demand | ||
| 03.11. | Tesla (NASDAQ:TSLA) and SpaceX (NASDAQ:SPCX) Merger Could Give Elon Musk 56% Voting Control | ||
| 03.11. | Ligand Pharmaceuticals (NDQ:LGND): A Toll Road Built on Pharmaceutical Innovation | ||
| 03.11. | Jazz Pharmaceuticals (NDQ:JAZZ): Evolving From A Sleep-Medicine Powerhouse to An Oncology Growth Story | ||
| 03.11. | Bloom Energy (NYSE:BE) Stock Surges 11% as Barclays Upgrade and 1 GW Power Agreement Spark Rally | ||
| 03.11. | Why Is Shopify (NASDAQ:SHOP) Stock Crashing Despite 32% Revenue Growth? | ||
| 03.11. | Apple (NASDAQ:AAPL) Stock Slides Despite US$114.5 Billion Revenue Beat: What Went Wrong? | ||
| 03.11. | Canberra Spends, the RBA Bends | ||
| 03.11. | Fulcrum Lithium (ASX:FUL) Is the Market Mispricing One of America's Biggest Lithium Resources | ||
| 03.11. | Reedy Lagoon (ASX:RLC) A$700k Raise Comes With More Than 25% Dilution | ||
| 03.11. | Janus Electric (ASX:JNS) US Expansion Just Got Much Bigger but Can Revenue Keep Up | ||
| 03.11. | QMines (ASX:QML) Why Is a Sovereign Backed Fund Doubling Down on Mt Chalmers | ||
| 02.11. | Amazon (NASDAQ:AMZN) Stock Rallies as Wall Street 'Buy' Upgrade Highlights 39% AWS Growth | ||
| 02.11. | Anthropic IPO: US$895 Billion AI Commitments Raise Profit Fears Despite US$17 Billion Revenue | ||
| 02.11. | Oracle (NYSE:ORCL) Stock Plunges 7% as US$20 Billion AI Funding Plan Sparks Dilution Fears | ||
| 02.11. | Halozyme Therapeutics (NDQ:HALO): A Royalty Compounder Entering Its Super Cycle! | ||
| 02.11. | Marvell (NASDAQ:MRVL) Stock Plunges 10% as US$115 Billion Lumentum Deal Sparks Valuation Fears | ||
| 02.11. | Exelixis (NDQ:EXEL): Its Reputation Was Built on a Blockbuster Drug, But Its Future Hinges on Replacing It | ||
| 02.11. | AMD (NASDAQ:AMD) Stock Crashes 11% Ahead of Earnings: Can AI Chip Growth Reverse the Selloff? | ||
| 02.11. | St Barbara (ASX:SBM) Management Thinks the Stock Is Cheap | ||
| 02.11. | Westpac (ASX:WBC) Is the Cost Problem Still Holding Back the Rerating? |